Effective treatment modality for adult respiratory distress syndrome using L-histidine
US5352691A · kind A · utility
3Cited by
0References
5Claims
0Family size
Inventor
Key dates
| Filing date | Feb 16, 1993 |
| Grant date | Oct 4, 1994 |
| Priority date | — |
| Expiry date | Feb 16, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A treatment modality for infectious diseases and pulmonary conditions that result from the inflammatory responses by tissues to infections by microorganisms, including but not limited to viruses, retroviruses, bacteria, or other microorganisms, or toxins that arise from microorganisms comprises administering an effective amount of histidine to the affected subject to combat the disease or the distress condition resulting therefrom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.